PAR 13.7% 29.0¢ paradigm biopharmaceuticals limited..

Ann: CHIKV study data published in Peer-Reviewed Journal, page-19

  1. 85 Posts.
    lightbulb Created with Sketch. 21
    Interestingly enough, iPPS being an anti-inflammatory, you would think that it would have negative impacts on healing and repair, not aid it with increasing regenerating myocytes to a damaged/infected area... This sounds positive but backwards as far as science goes so I may have to dig a little deeper into that comment. Exciting if this really happens!

    Inflammation is the first stage of the healing process and taking anti-inflammatories can actually inhibit the healing time of an injury or illness. As iPPS has anti-inflammatory properties I was worried that this would rule out people from taking it who were going through a healing process. I also wonder any contraindications with the use of iPPS or negative drug interactions that would preclude it from being used with other medications. The type of person likely to have OA would be over 60/70 years old and quite often would be on multiple drugs at this stage for management of a whole lot of other conditions
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.035(13.7%)
Mkt cap ! $101.4M
Open High Low Value Volume
25.5¢ 29.0¢ 25.0¢ $162.3K 595.5K

Buyers (Bids)

No. Vol. Price($)
2 49897 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 24504 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.